| Literature DB >> 33721392 |
Rongxin Li1, Yongjie Zhou2, Chao Liu1, Congcong Pei1, Weikang Shu1, Chaoqi Zhang1, Lianzhong Liu3, Liang Zhou4, Jingjing Wan1.
Abstract
Schizophrenia (SZ) detection enables effective treatment to improve the clinical outcome, but objective and reliable SZ diagnostics are still limited. An ideal diagnosis of SZ suited for robust clinical screening must address detection throughput, low invasiveness, and diagnosis accuracy. Herein, we built a multi-shelled hollow Cr2 O3 spheres (MHCSs) assisted laser desorption/ionization mass spectrometry (LDI MS) platform for the direct metabolic profiling of biofluids towards SZ diagnostics. The MHCSs displayed strong light absorption for enhanced ionization and microscale surface roughness with stability for the effective LDI of metabolites. We profiled urine and serum metabolites (≈1 μL) with the enhanced LDI efficacy in seconds. We discriminated SZ patients (SZs) from healthy controls (HCs) with the highest area under the curve (AUC) value of 1.000 for the blind test. We identified four compounds with optimal diagnostic power as a simplified metabolite panel for SZ and demonstrated the metabolite quantification for clinic use. Our approach accelerates the growth of new platforms toward a precision diagnosis in the near future.Entities:
Keywords: in vitro diagnostics (IVD); mass spectrometry; metabolites; multi-shelled hollow spheres; schizophrenia
Year: 2021 PMID: 33721392 DOI: 10.1002/anie.202101007
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336